IL33 and lymphedema: Interestingly, we found that patients with lymphedema have significantly increased expression of Th2-inducing cytokines (TSLP, IL33, IL25) in the epidermal cells of the lymphedematous limb, and that treatment with QBX258 decreased or normalized these changes.